These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 1972370

  • 1. [Effects of IT-066, a new histamine H2-receptor antagonist, on gastric acid secretion and experimental gastric ulcers in rats and dogs].
    Okabe S, Nishida T, Igata H, Takagi K.
    Nihon Yakurigaku Zasshi; 1990 May; 95(5):247-56. PubMed ID: 1972370
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
    Okabe S, Takagi K, Igata H, Kato S, Shimosako K, Yamaji Y, Seiki M.
    Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
    [Abstract] [Full Text] [Related]

  • 4. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
    Okabe S, Narita M, Nakaji S, Takinami Y, Kawano O, Misaki N.
    Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631
    [Abstract] [Full Text] [Related]

  • 5. Antisecretory and ulcer healing effects of S-0509, a novel CCK-B/gastrin receptor antagonist, in rats.
    Amagase K, Ikeda K, Okabe S.
    Dig Dis Sci; 1999 May; 44(5):879-88. PubMed ID: 10235591
    [Abstract] [Full Text] [Related]

  • 6. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
    Isobe Y, Nagai H, Muramatsu M, Aihara H, Otomo S.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1078-82. PubMed ID: 1979811
    [Abstract] [Full Text] [Related]

  • 7. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
    Tarutani M, Sakuma H, Shiratsuchi K, Mieda M.
    Arzneimittelforschung; 1985 Dec; 35(5):844-8. PubMed ID: 2862875
    [Abstract] [Full Text] [Related]

  • 8. [Effects of FRG-8813, a new-type histamine H2-receptor antagonist, on the healing of gastric and duodenal ulcer in rats and spontaneously ulcerative mice].
    Yamaura T, Shibata M, Chida Y, Inaba N, Onodera S, Ohnishi H.
    Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):411-20. PubMed ID: 1356898
    [Abstract] [Full Text] [Related]

  • 9. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
    Sekiguchi H, Hamada K, Aijima H, Taga F, Uchida H, Nishino K.
    Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
    [Abstract] [Full Text] [Related]

  • 10. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M, Yamaura T, Inaba N, Onodera S, Chida Y, Ohnishi H.
    Eur J Pharmacol; 1993 Apr 28; 235(2-3):245-53. PubMed ID: 8099553
    [Abstract] [Full Text] [Related]

  • 11. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
    Nagaya H, Inatomi N, Satoh H.
    Jpn J Pharmacol; 1991 Apr 28; 55(4):425-36. PubMed ID: 1886288
    [Abstract] [Full Text] [Related]

  • 12. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine].
    Okabe S, Takeuchi K, Okada M, Kumadaki Y, Nakata M, Nakata H.
    Nihon Yakurigaku Zasshi; 1989 Mar 28; 93(3):133-44. PubMed ID: 2567267
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
    Tanaka M, Banba M, Joko A, Moriyama Y.
    Nihon Yakurigaku Zasshi; 2001 Jun 28; 117(6):377-86. PubMed ID: 11436515
    [Abstract] [Full Text] [Related]

  • 14. Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog.
    Cavanagh RL, Buyniski JP.
    Aliment Pharmacol Ther; 1989 Jun 28; 3(3):299-313. PubMed ID: 2577694
    [Abstract] [Full Text] [Related]

  • 15. [Effect of an H+, K+-ATPase inhibitor, omeprazole (OPZ), on gastric acid secretion and gastric or duodenal lesion. Comparison with an H2-receptor antagonist, famotidine (FMD)].
    Haga K, Asano K, Osuga K, Maruyama Y.
    Nihon Yakurigaku Zasshi; 1988 Jul 28; 92(1):39-47. PubMed ID: 2906028
    [Abstract] [Full Text] [Related]

  • 16. Effect of NC-1300-O-3 on healing of acetic acid-induced gastric ulcers in rats.
    Okabe S, Takagi K, Inoue K.
    Jpn J Pharmacol; 1993 May 28; 62(1):25-33. PubMed ID: 8341026
    [Abstract] [Full Text] [Related]

  • 17. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
    Uchida M, Ohba S, Ikarashi Y, Misaki N, Kawano O.
    Arzneimittelforschung; 1993 Aug 28; 43(8):873-6. PubMed ID: 8105784
    [Abstract] [Full Text] [Related]

  • 18. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
    Shibata M, Yamaura T, Sekine A, Nishikawa M, Chida Y, Ohnishi H.
    Jpn J Pharmacol; 1990 Nov 28; 54(3):277-85. PubMed ID: 1982548
    [Abstract] [Full Text] [Related]

  • 19. [Effect of lafutidine, a novel antiulcer agent, on healing and relapse of acetic acid-induced gastric ulcer in rats].
    Onodera S, Tanaka M, Aoyama M, Arai Y, Shibata M, Yamaura T, Ohnishi H.
    Nihon Yakurigaku Zasshi; 1998 Mar 28; 111(3):167-75. PubMed ID: 9583080
    [Abstract] [Full Text] [Related]

  • 20. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K, Kato S, Yamamoto H, Okabe S.
    Arzneimittelforschung; 1996 Feb 28; 46(2):177-84. PubMed ID: 8720310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.